HPB & Spleen · 10 November 2024

Postoperative survival in cholangiocarcinoma has significantly improved.

Surgical strategies implemented after the launch of the cholangiocarcinoma screening and care program led to a significant increase in postoperative survival rates. Median survival time more than doubled from 14 months (2002-2013) to 40 months (2014-2021). Enhanced early-stage detection rose to 29.1%, with surgical margins improving notably (40% vs. 53.7%). These findings underscore the effectiveness of targeted screening in enhancing patient outcomes in the cholangiocarcinoma epidemic region.

Journal Article by Thanasukarn V, Srisuk T (…) Titapun A et 19 al. in World J Surg Oncol

read the whole article in World J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic liver resection with short-pitch dividing shortens hospital stay

Robotic liver resection using a close-to-open forceps technique was associated with no bile leakage and a shorter hospital stay than laparoscopic resection, even though more complex resections were performed in the robotic group.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →